These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Prostate artery embolization for benign prostatic hyperplasia: The hunt for the ideal patient population. Young S Diagn Interv Imaging; 2021 Mar; 102(3):119-120. PubMed ID: 33518450 [No Abstract] [Full Text] [Related]
85. Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization. Garcia-Monaco R; Garategui L; Kizilevsky N; Peralta O; Rodriguez P; Palacios-Jaraquemada J J Vasc Interv Radiol; 2014 Feb; 25(2):315-22. PubMed ID: 24325930 [TBL] [Abstract][Full Text] [Related]
86. Benign Prostatic Hyperplasia: Time to Upgrade Treatment Guidelines Regarding Prostatic Artery Embolization. Mahesh M Radiology; 2024 Mar; 310(3):e240415. PubMed ID: 38441094 [No Abstract] [Full Text] [Related]
87. Current Debates Regarding Optimal Patient Evaluation and Procedural Technique for Prostatic Artery Embolization. Powell T; Bhatia S; Ayyagari R Tech Vasc Interv Radiol; 2020 Sep; 23(3):100696. PubMed ID: 33308526 [TBL] [Abstract][Full Text] [Related]
88. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study. Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116 [TBL] [Abstract][Full Text] [Related]
89. Commentary on the "Safety of Prostatic Artery Embolization via Transradial Access versus Transfemoral Access". McNamara KL; Picel AC J Vasc Interv Radiol; 2024 Apr; 35(4):548-549. PubMed ID: 38103864 [No Abstract] [Full Text] [Related]
90. Patient selection and counseling before prostatic arterial embolization. A Pereira J; Bilhim T; Duarte M; Rio Tinto H; Fernandes L; Martins Pisco J Tech Vasc Interv Radiol; 2012 Dec; 15(4):270-5. PubMed ID: 23244723 [TBL] [Abstract][Full Text] [Related]
91. Re: Perioperative Blood Loss after Preoperative Prostatic Artery Embolization in Patients Undergoing Simple Prostatectomy: A Propensity Score-Matched Study. Barrera Gutierrez JC J Vasc Interv Radiol; 2022 Mar; 33(3):345-346. PubMed ID: 34838732 [No Abstract] [Full Text] [Related]
92. Fluoroscopy Time and Radiation Dose Using Liquid Embolic (n-butyl-2-cyanoacrylate) versus Microspheres for Prostatic Artery Embolization. Sanghvi J; Bamshad D; Galla N; Bai H; Garcia-Reyes K; Fischman A J Vasc Interv Radiol; 2024 Jan; 35(1):147-151.e1. PubMed ID: 37758023 [No Abstract] [Full Text] [Related]
93. MRI findings after prostatic artery embolization for treatment of benign hyperplasia. Frenk NE; Baroni RH; Carnevale FC; Gonçalves OM; Antunes AA; Srougi M; Cerri GG AJR Am J Roentgenol; 2014 Oct; 203(4):813-21. PubMed ID: 25247946 [TBL] [Abstract][Full Text] [Related]
94. Re: Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. Kaplan SA J Urol; 2015 Apr; 193(4):1316-7. PubMed ID: 25890535 [No Abstract] [Full Text] [Related]
95. Prostate Artery Embolization for Severe BPH in a Patient Unfit for Surgery. Ballon-Landa E; Bechis SK Urology; 2020 Feb; 136():e24-e25. PubMed ID: 31730941 [No Abstract] [Full Text] [Related]
96. Prostatic Artery Embolization Using Embosphere Microspheres for Prostates Measuring 80-150 cm(3): Early Results from a US Trial. Isaacson AJ; Raynor MC; Yu H; Burke CT J Vasc Interv Radiol; 2016 May; 27(5):709-14. PubMed ID: 27106645 [TBL] [Abstract][Full Text] [Related]
98. Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer Under Active Surveillance: Cancer Prostate Embolisation, a Pilot Study. Schmid HP; Hechelhammer L; Müllhaupt G Eur Urol; 2022 Jan; 81(1):121-122. PubMed ID: 34772549 [No Abstract] [Full Text] [Related]
99. [Clinical case: bladder necrosis after prostate embolization in a patient with prostatic hyperplasia]. Podoynicin AA; Mamedov EA; Amosov N; Garmash SV; Kuznecova DA; Shpot EV; Mashin GA; Maltsagova PS Urologiia; 2023 Mar; (1):88-91. PubMed ID: 37401689 [TBL] [Abstract][Full Text] [Related]